Literature DB >> 16791624

[What changes for rheumatologists in the G-DRG system 2006?].

A Liedtke-Dyong1, W Fiori, H-J Lakomek, J L Hülsemann, N Köneke, W Liman, N Roeder.   

Abstract

Once more, the revision of the German DRG catalogue 2006 provides for more accurate reimbursement, particularly for specialised medical services. The newly established DRG I97Z (Rheumatologische Komplexbehandlung bei Krankheiten und Störungen an Muskel-Skelett-System und Bindegewebe) for the complex and multimodal treatment of rheumatic diseases allows an accurate picture of clinical practice in specialized rheumatologic departments and hospitals. Using this specific DRG-description, it will be possible to reduce the financial pressure which results from the redistribution of budgets in the second year of the period of convergence. A precondition for the affected hospitals is to deal with budget planning and calculation of G-DRGs without calculated cost weights for 2006. In addition, this article discusses the relevance of other modifications to the G-DRG system, additional payments, the conditions for payment, the coding standards, and the classification systems for diagnosis and procedures.

Entities:  

Mesh:

Year:  2006        PMID: 16791624     DOI: 10.1007/s00393-006-0064-1

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  5 in total

1.  [Appropriate representation of rheumatology in the G-DRG system].

Authors:  H-J Lakomek; N Roeder; W Liman; W L Gross
Journal:  Z Rheumatol       Date:  2004-02       Impact factor: 1.372

2.  [Rheumatologic treatment in the G-DRG system].

Authors:  N Roeder; W Fiori; J L Hülsemann; N Könecke; H Lehmann; W Liman; H-J Lakomek
Journal:  Z Rheumatol       Date:  2004-02       Impact factor: 1.372

3.  [Changes for rheumatology in the G-DRG system 2005].

Authors:  W Fiori; N Roeder; H-J Lakomek; W Liman; N Köneke; J L Hülsemann; H Lehmann; A Wenke
Journal:  Z Rheumatol       Date:  2005-02       Impact factor: 1.372

4.  [The multimodal rheumatologic complex treatment (OPS 8-983)--challenges, solutions and perspectives].

Authors:  H-J Lakomek; W Fiori; K Buscham; J L Hülsemann; N Köneke; W Liman; E Märker-Hermann; N Roeder
Journal:  Z Rheumatol       Date:  2005-11       Impact factor: 1.372

5.  [Increasingly appropriate depiction of rheumatology for G-DRG reimbursement 2006].

Authors:  H J Lakomek; W Fiori; K Buscham; J Hülsemann; N Köneke; W Liman; E Märker-Hermann; N Roeder
Journal:  Z Rheumatol       Date:  2006-02       Impact factor: 1.372

  5 in total
  2 in total

Review 1.  [Clinical pathways in rheumatological inpatient treatment - a structured process management].

Authors:  H-J Lakomek; J L Hülsemann; T Küttner; K Buscham; N Roeder
Journal:  Z Rheumatol       Date:  2007-05       Impact factor: 1.372

2.  [Changes for the field of rheumatology in the G-DRG-System 2007].

Authors:  A Liedtke-Dyong; W Fiori; H-J Lakomek; A Wenke; W Liman; N Roeder
Journal:  Z Rheumatol       Date:  2007-07       Impact factor: 1.372

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.